PFE
Pfizer Inc.
NYSE
Healthcare
$29.57
+0.09
(+0.31%)
Updated: 10/16/2026, 8:55:00 PM
Open
$29.72
High
$29.73
Low
$29.38
Prev Close
$29.44
Volume
22.78M
Price History
Why Is PFE ▲ Up Today?
+0.31%
Full AI analysis generates after market close. Showing live price data.
Oct 16
▲
+0.3%
Pfizer (PFE) edges higher, outperforming sector on dividend news
Oct 15
▲
+0.7%
Pfizer Posts Modest Gain, Trails Sector Average
Oct 14
▲
+2.9%
Pfizer (PFE) Gains 2.92% as Stock Moves Past 50-Day SMA
Oct 13
▼
-0.2%
Pfizer (PFE) sees slight dip, significantly outperforms broader healthcare sector
Oct 12
▲
+0.5%
Pfizer edges higher, tracking sector's modest gains
Oct 9
▲
+1.5%
Pfizer (PFE) Posts Modest Gains Amid Positive Oncology Sector Sentiment
Oct 8
▼
-0.7%
Pfizer (PFE) Outperforms Sector Decline Amidst Positive FDA News
Oct 7
▲
+1.7%
Pfizer Outperforms Sector Amid Positive Investor Sentiment
Oct 6
▲
+0.2%
Pfizer sees modest gains, underperforming sector average
Oct 5
▼
-1.3%
Pfizer Shares Decline, Underperforming Broader Pharmaceutical Sector
Oct 2
▼
-1.2%
Pfizer Shares Decline Amid Broader Sector Gains
Oct 1
▼
-1.4%
Pfizer shares dip, underperforming sector on quiet news day
Sep 30
▼
-0.6%
Pfizer (PFE) sees modest decline, outperforming sector's larger drop
Sep 29
—
-0.0%
Pfizer (PFE) Posts Minor Decline, Outperforms Sector
Sep 28
▲
+0.2%
Pfizer Posts Modest Gain, Trails Sector Average
Sep 25
▲
+0.9%
Pfizer Outperforms Sector Amid Positive Industry Outlook
Sep 24
▲
+0.8%
Pfizer inches up, tracking broader pharmaceutical sector gains
Sep 23
▲
+0.8%
Pfizer Rises Modestly, Outperforming Declining Pharmaceutical Sector
Sep 22
▲
+0.6%
Pfizer Shares Edge Higher, Outperforming Sector Average
Sep 21
▲
+0.3%
Pfizer gains modestly on new HHS contract, lags sector
Sep 18
▼
-0.1%
Pfizer sees slight dip, underperforming sector average
Sep 17
▲
+0.7%
Pfizer posts modest gain amid positive pharmaceutical market outlook
Sep 16
▼
-0.5%
Pfizer Dips Slightly, Underperforming Sector Average
Sep 15
▼
-0.7%
Pfizer Dips Slightly, Underperforming Broader Sector
Sep 14
—
-0.1%
Pfizer (PFE) Edges Down Slightly on Modest Trading Volume
Sep 11
▲
+0.2%
Pfizer (PFE) Posts Slight Gain, Outperforming Sector
Sep 10
▼
-0.5%
Pfizer Experiences Modest Decline, Slightly Underperforming Sector
Sep 9
—
+0.0%
Pfizer Posts Minimal Gain Amidst Sector Downturn
Sep 8
▼
-2.3%
Pfizer Shares Decline, Underperforming Broader Sector
Sep 7
—
+0.0%
Pfizer Shares Remain Flat Amidst Quiet Trading Day
Financial Highlights
Income Statement
Revenue
$62.78B
Gross Profit
$46.08B
73.4% margin
Operating Income
$9.15B
14.6% margin
Net Income
$9.87B
15.7% margin
EPS (Diluted)
$1.72
Balance Sheet
Total Assets
$208.73B
Total Liabilities
$115.64B
Stockholders' Equity
$93.10B
Cash Flow
Operating Cash Flow
$13.08B
Investing Activities
$3.17B
Net Cash Flow
$242.0M
Highly Regarded Analysis for PFE
Get a deep-dive analysis including bull/bear cases, technical outlook, price targets, and key catalysts — powered by Highly Regarded's proprietary analysis engine.
Usually takes 10-20 seconds
Analyzing PFE...
Searching financial data and generating insights
Analysis couldn't be generated
Go Deeper on PFE
Key Stats
P/E Ratio
17.2x
EPS (Diluted)
$1.72
Gross Margin
73.4%
Operating Margin
14.6%
Net Margin
15.7%
Revenue (Qtr)
$62.78B
Shares Outstanding
5.69B
Next Earnings
Date
Nov 3, 2026
Time
Before Open
Quarter
Q3 2026
EPS Estimate
$0.73
PFE News
No recent news for PFE.
